The use of cell-based assays has the potential to revolutionize growing therapeutic areas, allowing for the development of more targeted and effective drugs.
TORONTO (PRWEB)
May 25, 2023
Cell-based assays in developing cutting-edge therapeutics have become increasingly important in recent years. With advancements in technology and the US Food and Drug Administration (FDA)’s removal of animal testing requirements, cell-based assays for QC testing have become a crucial component in the drug development process to demonstrate efficacy and potency.
In this webinar, attendees will gain knowledge on the latest cell-based technology as well as some important aspects of GMP requirements for bioassays and how these cell-based assays have been used to support drug development efforts for treating complement-mediated diseases., including insights into the challenges and solutions.
The relevance of cell-based assays is that they are customizable and can be tailored to specific needs. They are also readily available and have a high-throughput capacity, making them ideal for large-scale drug screening. In addition, cell-based assays provide a more accurate representation of how a drug will interact with human receptors, reduce variability, and cost than animal testing.
The use of cell-based assays has the potential to revolutionize growing therapeutic areas, allowing for the development of more targeted and effective drugs. It can also aid better understanding of complex diseases’ mechanisms, such as autoimmune disorders and inflammatory diseases.
Register for this webinar to learn how the use of GMP compliant cell-based assay can lead to the development of more effective and targeted drugs
Join experts from Svar Life Science, Therese Segerstein, MSc, Portfolio Director; Jordi Rodó Morera, PhD, Global Innovation & Scientific Lead; Azra Alajbegovic, PhD, Scientist; and Camilla Melin Fürst, PhD, Senior Scientist and Project Manager, for the live webinar on Wednesday, June 14, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Developing and Validating Robust Cell-Based Assays for GMP QC Testing.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: